Launching of the Medex website

22-02-2010 - Launching of the Medex website - Medex is determined to strengthen its presence on the Internet... Medex's News - Actualités de Medex -

About Medex

Medex is a biomedical laboratory established in 1988. Its operations are based in Saint Priest near Lyon (France).

Its products are sold in more than 10 countries.

Medex is specialised in contrast media injectors and medical disposables. The company offers injectors for CT and angiography examinations. It also has a large and comprehensive offering of disposables for CT and angiography examinations in addition to a selected range for MRI.

Medex is known on the market for its innovations :

- Soft Bag Injector, the only bag injector available on the market;
- Secufill in the safety patient line with its patented double threshold valve.
In 2004, Guerbet a pharmaceutical group specialised in medical imaging, acquired Medex in order to develop a global offering that now includes Soft Bag Injector and a new packaging for contrast media, Xenetix® in ScanBag®... About Medex - version française Medex by Guerbet -

Guerbet : Updated information about NSF and Dotarem

Villepinte, 2 july 2008 - ...What is Nephrogenic Systemic Fibrosis (NSF)?
NSF was first recognized in 1997 in 15 dialyzed patients and described in 2000 (1). This rare and highly debilitating disorder is characterized by extensive thickening and hardening of the skin associated with skin-colored to erythematous papules that coalesce into erythematous to brawny plaques with an “peau d’orange” appearance. Nodules are sometimes also described. Joint contractures may develop, with patients progressively becoming wheelchair-dependent. Patients often complain of pruritus, causalgia and sharp pains (2). The distal extremities are the most common area of involvement (with a distribution from ankles to mid-thighs and from wrists to midupper arms), followed by the trunk. The lesions are typically symmetrical. It is worth noting that the face and neck are virtually never involved (3)....
...Guerbet Pharmacovigilance Data
Guerbet markets meglumine gadoterate (Dotarem), a macrocyclic, ionic gadolinium chelate associated with a high thermodynamic and kinetic stability (15-19). So far more than eleven million patients have been exposed to Dotarem worldwide. With respect to NSF, Guerbet has recorded, to date, nine reports of patients who developed NSF after administration of gadolinium chelates.
There is no NSF case reported with Dotarem when it was injected alone.
These nine reports recorded by Guerbet and the Health Autorities are called “confounded cases”. The causal relationship to Dotarem is doubtful for the following reasons: linear gadolinium chelates were previously injected, the date of the onset of the disease and the chronology of injections...
... About the Group
Guerbet is the only pharmaceutical group fully dedicated to medical imaging. It has the most comprehensive range of x-ray and MRI contrast media available worldwide. These products assist medical professionals (radiologists, cardiologists, oncologists, etc.) in better diagnosing and treating their patients (cardiovascular, cancer, inflammatory and degenerative diseases)... [PDF] Guerbet's Press Release - PDF Communiqué de Presse Guerbet -